Prostate-specific membrane antigen is produced in tumor-associated neovasculature
- PMID: 10537328
Prostate-specific membrane antigen is produced in tumor-associated neovasculature
Abstract
Prostate-specific membrane antigen (PSMA), a type II transmembrane protein, was originally thought to be strictly expressed in prostatic tissue, but recent studies have demonstrated PSMA protein expression in nonprostatic tumor neovasculature as well. Using immunohistochemistry, reverse transcription-PCR assays, and in situ hybridization, we have demonstrated PSMA mRNA transcripts and protein expression in the endothelium of tumor-associated neovasculature of multiple nonprostatic solid malignancies. In addition, we found no PSMA mRNA or protein expression in the vascular endothelial cells of corresponding benign tissue examples. Our findings expand the possible therapeutic role of PSMA and establish it as a unique biomarker specifically produced and expressed by tumor-associated neovasculature but not produced or expressed by normal vessels.
Similar articles
-
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.Cancer Res. 1999 Jul 1;59(13):3192-8. Cancer Res. 1999. PMID: 10397265
-
Prostate-specific membrane antigen expression in normal and malignant human tissues.Clin Cancer Res. 1997 Jan;3(1):81-5. Clin Cancer Res. 1997. PMID: 9815541
-
Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.Int J Cancer. 2003 Nov 1;107(2):323-9. doi: 10.1002/ijc.11402. Int J Cancer. 2003. PMID: 12949815
-
[Detection of PSA mRNA and PSMA mRNA by RT-PCR].Nihon Rinsho. 2002 Dec;60 Suppl 11:151-5. Nihon Rinsho. 2002. PMID: 12599562 Review. Japanese. No abstract available.
-
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases.Urology. 1998 Oct;52(4):637-40. doi: 10.1016/s0090-4295(98)00278-7. Urology. 1998. PMID: 9763084 Review.
Cited by
-
Using shape effects to _target antibody-coated nanoparticles to lung and brain endothelium.Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10753-8. doi: 10.1073/pnas.1308345110. Epub 2013 Jun 10. Proc Natl Acad Sci U S A. 2013. PMID: 23754411 Free PMC article.
-
Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices.Biomed Microdevices. 2012 Apr;14(2):401-7. doi: 10.1007/s10544-011-9616-5. Biomed Microdevices. 2012. PMID: 22143878 Free PMC article.
-
Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner.Int J Nanomedicine. 2012;7:4341-52. doi: 10.2147/IJN.S34381. Epub 2012 Aug 6. Int J Nanomedicine. 2012. PMID: 22915856 Free PMC article.
-
Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-_targeted Tracers?Bioconjug Chem. 2020 Feb 19;31(2):375-395. doi: 10.1021/acs.bioconjchem.9b00758. Epub 2020 Jan 6. Bioconjug Chem. 2020. PMID: 31855410 Free PMC article. Review.
-
Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane.J Carcinog. 2006 Aug 15;5:21. doi: 10.1186/1477-3163-5-21. J Carcinog. 2006. PMID: 16911781 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous